MétaCan
Menu
Back to cohort
Record W4381436646 · doi:10.1016/j.xcrm.2023.101089

Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective

2023· review· en· W4381436646 on OpenAlexafffund
Fanny M. Elahi, Suvarna Alladi, Sandra E. Black, Jurgen A.H.R. Claassen, Charles DeCarli, Timothy M. Hughes, Justine Moonen, Nicholas M. Pajewski, Brittani R. Price, Claudia L. Satizábal, C. Elizabeth Shaaban, Nárlon Cássio Boa Sorte Silva, Heather M. Snyder, Lukas Sveikata, Jeff D. Williamson, Frank J. Wolters, Atticus H. Hainsworth

Bibliographic record

VenueCell Reports Medicine · 2023
Typereview
Languageen
FieldMedicine
TopicBlood Pressure and Hypertension Studies
Canadian institutionsUniversity of British ColumbiaHealth Sciences CentreUniversity of TorontoSunnybrook Health Science Centre
FundersMedical Research FoundationNational Institute of Neurological Disorders and StrokeAlzheimer NederlandZonMwNational Institutes of HealthSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungAlzheimer's SocietyMichael Smith Health Research BCMedical Research CouncilNHS Innovation AcceleratorBiogenAmerican Academy of NeurologyBarwon Health FoundationU.S. Department of Veterans AffairsBritish Heart FoundationAlzheimer's Drug Discovery FoundationNational Institute on AgingAlzheimer's AssociationCanadian Institutes of Health ResearchAlzheimer’s SocietyNational Science Foundation
KeywordsDementiaSprintCognitionClinical trialMedicineBlood pressurePsychological interventionPhysical therapyIntensive care medicinePhysical medicine and rehabilitationPsychiatryDiseaseInternal medicine

Abstract

fetched live from OpenAlex

A large interventional trial, the Systolic Blood Pressure Intervention Trial sub-study termed Memory and Cognition in Decreased Hypertension (SPRINT-MIND), found reduced risk of cognitive impairment in older adults with intensive, relative to standard, blood-pressure-lowering targets (systolic BP < 120 vs. <140 mm Hg). In this perspective, we discuss key questions and make recommendations for clinical practice and for clinical trials, following SPRINT-MIND. Future trials should embody cognitive endpoints appropriate to the participant group, ideally with adaptive designs that ensure robust answers for cognitive and cardiovascular endpoints. Reliable data from diverse populations, including the oldest-old (age > 80 years), will maximize external validity and global implementation of trial findings. New biomarkers will improve phenotyping to stratify patients to optimal treatments. Currently no antihypertensive drug class stands out for dementia risk reduction. Multi-domain interventions, incorporating lifestyle change (exercise, diet) alongside medications, may maximize global impact. Given the low cost and wide availability of antihypertensive drugs, intensive BP reduction may be a cost-effective means to reduce dementia risk in diverse, aging populations worldwide.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.016
metaresearch head score (Gemma)0.033
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.016
Threshold uncertainty score0.083

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0160.033
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0060.003
Bibliometrics0.0030.004
Science and technology studies0.0000.001
Scholarly communication0.0030.003
Open science0.0020.001
Research integrity0.0040.005
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.284
GPT teacher head0.510
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations29
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueCell Reports MedicineSame topicBlood Pressure and Hypertension StudiesFrench-language works237,207